Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis

This publication has 9 references indexed in Scilit:

• Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients
  PLOS ONE, 2013
• Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
  PLOS ONE, 2012
• Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort
  The International Journal of Tuberculosis and Lung Disease, 2012
• Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India
  PLOS ONE, 2011
• Adverse Effects of Multidrug-Resistant Tuberculosis Treatment With a Standardized Regimen: A Report From Iran
  American Journal of Therapeutics, 2011
• Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa
  PLOS ONE, 2009
• Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study
  The Lancet, 2005
• Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens
  Chest, 2000
• Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
  New England Journal of Medicine, 1993